Genocea Biosciences, Inc.

GNCACIK 0001457612 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0024

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Genocea Biosciences, Inc.

Name	Roles	Filings
New Enterprise Associates 16, L.P.	10% Owner	1
Sandell Scott D	10% Owner	1
Siber George	Director	1
Sonsini Peter W.	10% Owner	1
Walker Paul Edward	10% Owner	1

Showing 16-20 of 20

Per pagePrevPage 4 of 4

All filings

31 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 3, 2022	Clark William D President and CEO · Director	SSale	4,023	$0.06	$241
Jun 3, 2022	Flechtner Jessica Baker Chief Scientific Officer	SSale	1,578	$0.06	$95
Jun 3, 2022	Duvall Diantha CHIEF FINANCIAL OFFICER	SSale	1,355	$0.06	$81
Jun 2, 2022	Clark William D President and CEO · Director	SSale	117,244	$0.0617	$7,234
Jun 2, 2022	Sumer Jacquelyn L CHIEF LEGAL & COMPLIANCE OFF	SSale	2,500	$0.0601	$150

Showing 1-5 of 31

Per pagePage 1 of 7Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value